Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events | MicrobiomeTrials
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2022-07-08Est. Completion: 2026-10-26
Enrollment target: 610 participants
Locations
Heart Center Research Llc, Huntsville, Alabama, United States
Alaska Heart and Vascular, Anchorage, Alaska, United States
Cardiovascular Res Found, Beverly Hills, California, United States
UC San Diego Health, La Jolla, California, United States
Stanford Health Care, Stanford, California, United States
Lundquist Inst BioMed at Harbor, Torrance, California, United States
Bridgeport Hospital, Bridgeport, Connecticut, United States
George Washington Univ Medical Ctr, Washington D.C., District of Columbia, United States
Inpatient Research Clinical LLC, Miami Lakes, Florida, United States
NorthShore University Health System, Evanston, Illinois, United States
Reid Physician Associates, Richmond, Indiana, United States
Midwest Heart and Vascular Spec, Overland Park, Kansas, United States
Anderson Medical Research, Ft. Washington, Maryland, United States
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
R Ins For Heart And Vascular Health, Reno, Nevada, United States
Cardio Metabolic Institute, Somerset, New Jersey, United States
Other microbiome trials you might be interested in